Novolog (Pharm-Up 1966) Ltd (TLV: NVLG)

Novolog (Pharm-Up 1966) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	239.95	232.94	172.81	238.71	176.44	185.11
Cash & Short-Term Investments	239.95	232.94	172.81	238.71	176.44	185.11
Cash Growth	-16.38%	34.80%	-27.61%	35.29%	-4.68%	71.45%
Accounts Receivable	1,853	1,560	1,310	1,286	1,260	1,247
Other Receivables	56.91	53.43	36.54	20.28	10.99	25.66
Receivables	1,910	1,613	1,346	1,306	1,271	1,272
Inventory	335.45	247.33	189.03	186.79	255.64	214.55
Prepaid Expenses	-	11.35	9.56	10.25	4.68	3.59
Other Current Assets	-	1.86	0.76	-	-	-
Total Current Assets	2,485	2,106	1,719	1,742	1,708	1,675
Property, Plant & Equipment	304.31	321.4	306.62	224.77	191.24	220.13
Long-Term Investments	16.81	16.2	42.31	23.4	0.5	0.5
Goodwill	159.67	162.69	206.96	161.06	144.91	135.71
Other Intangible Assets	152.29	138.43	121.92	97.4	75.78	75.83
Long-Term Accounts Receivable	27.55	29.62	32.15	33.94	34.93	7.74
Long-Term Deferred Tax Assets	4.21	4.82	1.78	0.77	1.04	0.29
Other Long-Term Assets	12.31	9	6.29	5.04	30.2	34.59
Total Assets	3,162	2,789	2,437	2,289	2,187	2,150
Accounts Payable	2,471	2,079	1,662	1,616	1,663	1,660
Accrued Expenses	-	56.53	49.43	43.48	32.97	29.57
Current Portion of Long-Term Debt	-	0.91	1.15	0.39	0.06	0.06
Current Portion of Leases	26.55	26.6	22.06	20.14	16.2	16.37
Current Income Taxes Payable	5.47	6.55	6.52	4.59	2.61	1
Other Current Liabilities	72.41	15.65	13.42	4.3	18.39	7.04
Total Current Liabilities	2,575	2,185	1,754	1,689	1,734	1,714
Long-Term Debt	-	0.07	0.97	0.92	0.43	0.5
Long-Term Leases	176.79	187.59	188.6	145.37	137.54	141.09
Long-Term Deferred Tax Liabilities	14.15	16.41	19.71	17.63	16.22	16.78
Other Long-Term Liabilities	1.4	1.69	6.46	1.42	0.5	11.6
Total Liabilities	2,769	2,392	1,972	1,858	1,891	1,886
Common Stock	5.11	5.11	5.09	5.07	4.64	4.64
Additional Paid-In Capital	347.19	345.07	340.97	339.73	218.91	218.83
Retained Earnings	39.55	32.67	91.58	75.97	65.65	37.58
Comprehensive Income & Other	-14.07	-11.77	-1.93	3.61	5.49	2.74
Total Common Equity	377.78	371.08	435.7	424.37	294.69	263.78
Minority Interest	15.35	25.04	28.78	5.86	0.98	-
Shareholders' Equity	393.14	396.12	464.48	430.23	295.67	263.78
Total Liabilities & Equity	3,162	2,789	2,437	2,289	2,187	2,150
Total Debt	203.34	215.18	212.77	166.81	154.24	158.02
Net Cash (Debt)	36.61	17.76	-39.97	71.9	22.2	27.09
Net Cash Growth	-56.39%	-	-	223.81%	-18.03%	-74.77%
Net Cash Per Share	0.07	0.03	-0.08	0.14	0.05	0.07
Filing Date Shares Outstanding	510.72	510.72	508.7	506.57	463.49	463.49
Total Common Shares Outstanding	510.72	510.72	508.7	506.57	463.49	463.49
Working Capital	-89.94	-78.39	-35.81	52.94	-25.64	-38.12
Book Value Per Share	0.74	0.73	0.86	0.84	0.64	0.57
Tangible Book Value	65.82	69.97	106.82	165.91	74	52.23
Tangible Book Value Per Share	0.13	0.14	0.21	0.33	0.16	0.11
Machinery	-	148.01	131.88	155.63	133.06	141.13
Leasehold Improvements	-	131.41	113.03	74.47	71	66.27

Source: S&P Capital IQ. Standard template. Financial Sources.